Frederick G. Vogt, Interim CEO & General Counsel: Iovance Biotherapeutics IOVA Buy · Filed 25/05/16

Trade details

Type: Insider buy
Amount: $42,250
Shares · price: 25,000 sh · $1.69 a share
Held after: 374,646 sh
Stock: Iovance Biotherapeutics IOVA
Person: Frederick G. VogtInterim CEO & General Counsel
Trade date: 25/05/14
Filed: 25/05/16
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +7.2%

Iovance Biotherapeutics trades, last 26 weeks

What else happened in Iovance Biotherapeutics around then

Filed or reported within 30 days of the trade day · 25/04/14~25/06/13

Frederick G. Vogt's recent trades

No other trades yet.